Posts published in “Tentative Approval”

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…